These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 8995245
1. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. Dick LR, Cruikshank AA, Destree AT, Grenier L, McCormack TA, Melandri FD, Nunes SL, Palombella VJ, Parent LA, Plamondon L, Stein RL. J Biol Chem; 1997 Jan 03; 272(1):182-8. PubMed ID: 8995245 [Abstract] [Full Text] [Related]
2. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone. Dick LR, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, Stein RL. J Biol Chem; 1996 Mar 29; 271(13):7273-6. PubMed ID: 8631740 [Abstract] [Full Text] [Related]
4. Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. Craiu A, Gaczynska M, Akopian T, Gramm CF, Fenteany G, Goldberg AL, Rock KL. J Biol Chem; 1997 May 16; 272(20):13437-45. PubMed ID: 9148969 [Abstract] [Full Text] [Related]
6. The Leishmania chagasi proteasome: role in promastigotes growth and amastigotes survival within murine macrophages. Silva-Jardim I, Horta MF, Ramalho-Pinto FJ. Acta Trop; 2004 Jul 16; 91(2):121-30. PubMed ID: 15234661 [Abstract] [Full Text] [Related]
7. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Demasi M, Shringarpure R, Davies KJ. Arch Biochem Biophys; 2001 May 15; 389(2):254-63. PubMed ID: 11339815 [Abstract] [Full Text] [Related]
8. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses. Schwarz K, de Giuli R, Schmidtke G, Kostka S, van den Broek M, Kim KB, Crews CM, Kraft R, Groettrup M. J Immunol; 2000 Jun 15; 164(12):6147-57. PubMed ID: 10843664 [Abstract] [Full Text] [Related]
10. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. Teckman JH, Burrows J, Hidvegi T, Schmidt B, Hale PD, Perlmutter DH. J Biol Chem; 2001 Nov 30; 276(48):44865-72. PubMed ID: 11577074 [Abstract] [Full Text] [Related]
13. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme. Ostrowska H, Wojcik C, Omura S, Worowski K. Biochem Biophys Res Commun; 1997 May 29; 234(3):729-32. PubMed ID: 9175783 [Abstract] [Full Text] [Related]
15. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. Science; 1995 May 05; 268(5211):726-31. PubMed ID: 7732382 [Abstract] [Full Text] [Related]
16. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Imajoh-Ohmi S, Kawaguchi T, Sugiyama S, Tanaka K, Omura S, Kikuchi H. Biochem Biophys Res Commun; 1995 Dec 26; 217(3):1070-7. PubMed ID: 8554559 [Abstract] [Full Text] [Related]
17. Proteasome-dependent degradation of cytosolic chaperonin CCT. Yokota S, Kayano T, Ohta T, Kurimoto M, Yanagi H, Yura T, Kubota H. Biochem Biophys Res Commun; 2000 Dec 20; 279(2):712-7. PubMed ID: 11118350 [Abstract] [Full Text] [Related]